GenomeArc Inc.

GenomeArc is a leading analytic platform for high precision interpretation of genomes. Integrating artificial intelligence along with genomic and clinical data for meaningful interpretation of genetic variants.

GenomeArc is committed to resolve genetic determinants for millions of patients with genetic diseases. We want to impact on human health by implementing genomic medicine.

Discover GenomeArc
hero

End to end Solution: GenomeArc team provide enhanced support for small to large scale genomic projects to support sequencing, variant calling and tertiary genomic interpretation data analysis. GenomeArc is affiliated or in collaboration with many institutions, including: !

Horizon Platform is fully automated for variant interpretations and pathogenicity predictions for diseases and traits. Our platform provides rapid answers to help clinicians with actionable insights. !


Horizon platform with high diagnostic yield can analyze, interpret and report causal variants in minutes. We use our proprietary variant databases that involves over 1000 published clinical genomic studies.


Horizon is efficient, scalable and fast to

shape shape

Faster Automated Analysis

Lorem ipsum dolor sit amet,consetetur sadipscing elitr, seddiam nonu eirmod tempor invidunt labore.

Learn More
shape shape

Validated Prediction Algorithms

Lorem ipsum dolor sit amet,consetetur sadipscing elitr, seddiam nonu eirmod tempor invidunt labore.

Learn More
shape shape

Accurate OMICs Databases

Lorem ipsum dolor sit amet,consetetur sadipscing elitr, seddiam nonu eirmod tempor invidunt labore.

Learn More

Horizon features An intuitive AI powered platform

⇒ Automated ACMG guided variant pathogenicity predictions

⇒ Integrates clinical phenotypic data

⇒ Fast variant analysis for routine and NICU/PICU cases

⇒ Proprietary clinical genetic databases

⇒ Custom investigation of variants and automated reporting

⇒ Custom integration of secondary clinical data

Try it ...
about
shape
shape

Modern design with Essential Features

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, seiam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing.

Try it Free

RESEARCH Tell everything about us...


We just need to list all our scientific publications: Click here

about
about

Scientific Advisory Board

Mohammed Uddin (Dafil) PhD

Associate Professor, College of Medicine, MBRU, Dubai Founder and CEO, GenomeArc Inc., Toronto, Canada

Marc Woodbury-Smith, MD, PhD

Senior Lecturer, Biosciences Institute, Newcastle University,

Newcastle Upon Tyne, UK

Proton Rahman, MD, FRCPC, FCAHC

Professor of Medicine, Faculty of Medicine,

Memorial University, Canada

Bakhrom K. Berdiev, MD, PhD

Associate Professor, College of Medicine,

Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai

Wolfgang Küebler, MD, PhD

Director, Institute of Physiology,

Charité - Universitätsmedizin Berlin, Germany Professor, Associate Scientist, University of Toronto, Canada

shape

We are a team of geneticist, clinicians, bioinformaticians, software engineers, and ethicists, committed to solving genetic diseases, to advance science and benefit humanity. Our research driven approach is helping us constantly updating and solving the most complex problems in genomic medicine.!

shape shape

Research

GenomeArc research teams work on cutting-edge genomic medicine, and artificial intelligence, to provide precision solutions. A multi disciplinary team of geneticist, clinicians, bioinformatician and software engineers collaborate to build systems that can impact human health and society.

shape shape

Engineering

At GenomeArc, our engineering team constantly creating new algorithm based on genomic and clinical datasets. Development of algorithms helps us unlock the most complex problems in genomic medicine.

shape shape

Ethics

Our interdisciplinary group of bio ethics policy experts, and researchers work with other groups in academia, civil society, and the broader AI community to address using new genomic medicine technologies in light of ethics and societal impact.